Malaysia is investigating 27 people for allegedly spreading misinformation about the deadly new coronavirus, officials said Friday, as governments across Asia crack down on false claims about the epidemic.

The virus has so far killed more than 2,200 people and infected over 75,000, mostly in China, and spread to dozens of countries and territories including Malaysia, which has 22 confirmed cases.

It has triggered an explosion of false information online, from vastly inflated death tolls to vaccine conspiracies and misleading bat soup videos.

Several Asian countries have made arrests over the spread of falsehoods, and Singapore this week ordered Facebook to block an anti-government page in the city-state that it says was peddling misinformation about the pathogen.

Of the 27 people under investigation in Malaysia, four have already been charged in court and another four were expected to be charged Friday, officials from the communications ministry and prime minister’s department told AFP.

No details were provided about the misinformation they are accused of spreading. Officials warned a broader crackdown was planned.

“If you are found to be involved in any act (of) spreading lies… we will go after you and we don’t care who you are,” Mohamed Hanipa Maidin, deputy minister in the prime minister’s department, told reporters.

Earlier this month, a Malaysian journalist was charged for making statements that could cause public alarm over social media posts related to the virus, including one in which she raised concerns about the arrival of Chinese tourists on a cruise ship.

Officials have warned that false information about the virus could be “inflammatory” in Muslim-majority, multi-ethnic Malaysia, where race and religion are considered sensitive topics.

Some observers have raised concerns that overzealous crackdowns could curb civil liberties.

“There is a thin line between the government taking proactive steps against (misinformation) and the government infringing on rights to free speech,” Asrul Hadi Abdullah Sani, a political analyst from BowerGroupAsia consultancy, told AFP.

– AFP

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Brad Bowyer: "When questions arise just asserting something is false or giving irrelevant information does not answer valid questions"

by Brad Bowyer As many have asked for my detailed views or…

【选举】IHH收购印度医疗机构受阻 惟前总裁陈诗龙荣休今年参选

人民行动党上周在线上介绍了27名新面孔,其中一人是55岁的IHH医疗保健集团管理层的前总裁兼董事经理,陈诗龙医生。令人感到疑惑的是,在他离职时,IHH正面对收购印度医疗机构富通的交易纠纷,而他似乎没选择留下来提供协助。 陈诗龙于2014年1月至2019年12月在IHH任职。然而在他去年合约结束,选择退休。 IHH医疗保健集团在我国、马来西亚、中国、土耳其和印度都有业务,也是我国和马来西亚的上市公司。其旗下的百汇班台(Parkway Pantai Ltd)更是集团的御宝,在亚洲拥有医院网络,包括我国的伊丽莎白医院、伊丽莎白诺维娜医院、鹰阁医院和百汇东岸医院。 行动党委派陈诗龙医生出战马林百列集选区,直接对垒工人党。 IHH在印度收购富通受阻 IHH医疗保健公司在2018年7月,成功赢得收购印度第二大医院经营机构-富通保健股权的竞标战,并于同年11月通过优先配股购买31.1巴仙股权,还打算随后收购额外的26巴仙股权。但是日本制药公司第一三共株式会社(Daiichi Sankyo)和富通保健的创办人辛格兄弟对簿公堂,因此印度最高法院下令IHH暂缓收购交易。辛格兄弟当时也接受印度当局的欺诈调查。 在2019年11月15日,印度法院裁定富通保健前持有人,辛格兄弟和富通藐视法庭罪名成立,也表示或对当时已经由IHH掌控的富通公司展开藐视法庭审讯。这是因为法院指IHH和富通的部分交易,被视为违反了2018年12月的庭令。 法院当时曾对双方部分交易展开调查,甚至调查富通董事会和管理层的详情,发现相关交易都是非常仓促和秘密在进行,进而违反了2018年所发出的庭令。 印度当局下令调查富通…

Why are the 98,289 positive COVID-19 cases via serology tests not included in total tally?

On Monday (14 December), the Ministry of Health said in a statement…

CocoLuscious recalls products due to presence of undeclared allergen

The Food Standards Australia New Zealand had earlier issued an alert that…